BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ai L, Xu Z, Yang B, He Q, Luo P. Sorafenib-associated hand-foot skin reaction: practical advice on diagnosis, mechanism, prevention, and management. Expert Rev Clin Pharmacol 2019;12:1121-7. [PMID: 31679411 DOI: 10.1080/17512433.2019.1689122] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Pandy JGP, Franco PIG, Li RK. Prophylactic strategies for hand-foot syndrome/skin reaction associated with systemic cancer treatment: a meta-analysis of randomized controlled trials. Support Care Cancer 2022. [PMID: 35655045 DOI: 10.1007/s00520-022-07175-3] [Reference Citation Analysis]
2 Nie W, Lu Y, Pan C, Gao J, Luo M, Du J, Wang J, Luo P, Zhu H, Che J, He Q, Dong X. Design, Synthesis, and Biological Evaluation of Quinazoline Derivatives with Covalent Reversible Warheads as Potential FGFR4 Inhibitors. Bioorganic Chemistry 2022. [DOI: 10.1016/j.bioorg.2022.105673] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Li T, Shi Q, Liu J, Wang Y, Zhou C, Wang C, Ju S, Huang S, Yang C, Chen Y, Bai Y, Xiong B. Donafenib-Loaded Callispheres Beads Embolization in a VX2 Liver Tumor: Investigating Efficacy, Safety, and Improvement of Tumor Angiogenesis After Embolization. J Hepatocell Carcinoma 2021;8:1525-35. [PMID: 34888263 DOI: 10.2147/JHC.S337097] [Reference Citation Analysis]
4 Du J, Yan H, Xu Z, Yang B, He Q, Wang X, Luo P. Cutaneous toxicity of FDA-approved small-molecule kinase inhibitors. Expert Opin Drug Metab Toxicol 2021. [PMID: 34743659 DOI: 10.1080/17425255.2021.2004116] [Reference Citation Analysis]
5 Machado CB, de Pinho Pessoa FMC, da Silva EL, da Costa Pantoja L, Ribeiro RM, de Moraes Filho MO, de Moraes MEA, Montenegro RC, Burbano RMR, Khayat AS, Moreira-Nunes CA. Kinase Inhibition in Relapsed/Refractory Leukemia and Lymphoma Settings: Recent Prospects into Clinical Investigations. Pharmaceutics 2021;13:1604. [PMID: 34683897 DOI: 10.3390/pharmaceutics13101604] [Reference Citation Analysis]
6 Che J, Dai X, Gao J, Sheng H, Zhan W, Lu Y, Li D, Gao Z, Jin Z, Chen B, Luo P, Yang B, Hu Y, He Q, Weng Q, Dong X. Discovery of N-((3S,4S)-4-(3,4-Difluorophenyl)piperidin-3-yl)-2-fluoro-4-(1-methyl-1H-pyrazol-5-yl)benzamide (Hu7691), a Potent and Selective Akt Inhibitor That Enables Decrease of Cutaneous Toxicity. J Med Chem 2021;64:12163-80. [PMID: 34375113 DOI: 10.1021/acs.jmedchem.1c00815] [Reference Citation Analysis]
7 Rodriguez-Gil JL, Bianconi SE, Farhat N, Kleiner DE, Nelson M, Porter FD. Hepatocellular carcinoma as a complication of Niemann-Pick disease type C1. Am J Med Genet A 2021. [PMID: 34138521 DOI: 10.1002/ajmg.a.62382] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
8 Xia H, Zhou C, Luo Z, Zhang P, Zhu L, Gong Z. Apatinib-Induced Hand-Foot Skin Reaction in Chinese Patients With Liver Cancer. Front Oncol 2021;11:624369. [PMID: 33981598 DOI: 10.3389/fonc.2021.624369] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Chen J, Wang Z. How to conduct integrated pharmaceutical care for patients with hand-foot syndrome associated with chemotherapeutic agents and targeted drugs. J Oncol Pharm Pract 2021;27:919-29. [PMID: 33874817 DOI: 10.1177/10781552211009291] [Reference Citation Analysis]
10 Chen YS, Chang HS, Hsiao HH, Chen YF, Kuo YP, Yen FL, Yen CH. Identification of Beilschmiedia tsangii Root Extract as a Liver Cancer Cell-Normal Keratinocyte Dual-Selective NRF2 Regulator. Antioxidants (Basel) 2021;10:544. [PMID: 33915987 DOI: 10.3390/antiox10040544] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Han H, Lin T, Fang Z, Zhou G. RBM23 Drives Hepatocellular Carcinoma by Activating NF-κB Signaling Pathway. Biomed Res Int 2021;2021:6697476. [PMID: 33791378 DOI: 10.1155/2021/6697476] [Reference Citation Analysis]
12 Shou L, Shao T, Zhao F, Chen S, Chen Q, Shu Q. The Efficacy and Safety of the Shouzu Ning Decoction Treatment for Multi-Kinase Inhibitors-Associated Severe Hand-Foot Skin Reaction. Cancer Manag Res 2021;13:45-53. [PMID: 33442293 DOI: 10.2147/CMAR.S285002] [Reference Citation Analysis]
13 Carlberg VM, Davies OMT, Brandling-Bennett HA, Leary SES, Huang JT, Coughlin CC, Gupta D. Cutaneous reactions to pediatric cancer treatment part II: Targeted therapy. Pediatr Dermatol 2021;38:18-30. [PMID: 33378085 DOI: 10.1111/pde.14495] [Reference Citation Analysis]